BIOLINERX LTD's ticker is BLRXXXXX and the CUSIP is 09071M106. A total of 24 filers reported holding BIOLINERX LTD in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,000 | 0.0% | 2,000 | -12.1% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 2,275 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 2,275 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | 0.0% | 2,275 | +13.8% | 0.00% | – |
| Q2 2018 | $2,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2018 | $2,000 | -77.8% | 2,000 | -77.8% | 0.00% | – |
| Q4 2017 | $9,000 | +50.0% | 9,000 | +80.0% | 0.00% | – |
| Q3 2017 | $6,000 | +50.0% | 5,000 | 0.0% | 0.00% | – |
| Q2 2017 | $4,000 | -20.0% | 5,000 | 0.0% | 0.00% | – |
| Q1 2017 | $5,000 | 0.0% | 5,000 | 0.0% | 0.00% | – |
| Q4 2016 | $5,000 | -89.1% | 5,000 | -87.5% | 0.00% | -100.0% |
| Q3 2016 | $46,000 | +43.8% | 40,000 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $32,000 | -22.0% | 40,000 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $41,000 | -10.9% | 40,000 | +14.3% | 0.00% | 0.0% |
| Q4 2015 | $46,000 | – | 35,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Senvest Management, LLC | 3,543,300 | $2,835,000 | 0.23% |
| Opaleye Management Inc. | 250,000 | $223,000 | 0.15% |
| Benchmark Capital Advisors | 44,000 | $35,000 | 0.03% |
| MENTA CAPITAL LLC | 98,647 | $79,000 | 0.01% |
| NEXT Financial Group, Inc | 39,500 | $31,000 | 0.01% |
| Cutter & CO Brokerage, Inc. | 25,000 | $20,000 | 0.01% |
| Orbimed Advisors | 1,038,600 | $831,000 | 0.01% |
| TWO SIGMA SECURITIES, LLC | 17,771 | $14,000 | 0.01% |
| Alyeska Investment Group, L.P. | 611,947 | $490,000 | 0.01% |
| A.R.T. Advisors, LLC | 25,890 | $20,000 | 0.00% |